Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 1,500 shares at $76.28 ($117K) on 2018-12-03, disclosed to the SEC on 2018-12-06.
Scheduled sale ($117k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.28 | 113 | $9K | 7.4% |
| 2 | $77.93 | 1,087 | $85K | 72.2% |
| 3 | $78.60 | 100 | $8K | 6.7% |
| 4 | $80.40 | 200 | $16K | 13.7% |
| Total | $78.18 avg | 1,500 | $117K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |